Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry.
Raghubir Singh KhedarRajeev GuptaKrishnakumar SharmaKartik MittalHarshad C AmbaliyaJugal B GuptaSurendra SinghSwati SharmaYogendra SinghAlok MathurPublished in: BMJ open (2022)
High levels of biomarkers-hsCRP, D-dimer, IL-6, LDH, ferritin and NLR-in COVID-19 are associated with more severe illness and higher in-hospital mortality. NLR, a widely available investigation, provides information similar to more expensive biomarkers.